Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000904454-25-000219·Beta Bionics, Inc.
Schedule 13G ownership disclosure
Beta Bionics Inc
Common Stock · CUSIP: 08659B102
Event date: 2025-04-02
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Sands Capital Life Sciences Pulse Fund II. L.P.
Shares: 3,154,409.00 · Class: 7.3%
- Sands Capital Ventures, LLC
Shares: 3,154,409.00 · Class: 7.3%
- Frank M. Sands
Shares: 3,154,409.00 · Class: 7.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000904454-25-000219
- Form type
- SCHEDULE 13G
- Filer
- Beta Bionics, Inc.
- CIK
- CIK 1674632
- Filed
- Apr 09, 2025
- Reporting period
- Apr 02, 2025
- Description
- Schedule 13G beneficial ownership